The results are part of the company’s strategy to “diversify our geographic footprint” and rely less on the US market, Chief Executive Officer Stephane Bancel said in an interview.
A hantavirus vaccine is currently in preclinical development, but a publicly available shot is likely years away. Other ...
The head of the U.S. Food and Drug Administration, Dr. Marty Makary, is resigning after a rocky tenure that drew months of ...
WASHINGTON (AP) — The head of the Food and Drug Administration , Dr. Marty Makary, is resigning after a rocky tenure that ...
Caption: A four-year-old child receives a dose of the Moderna COVID-19 vaccine in New York in June. Health Canada approved the kids' vaccine l ...
An mRNA-based flu shot could make a huge difference in flu prevention, allowing scientists to pick a better strain match.
April 24 (Reuters) - German biotech company CureVac sued Moderna (MRNA.O), opens new tab in Delaware federal court on Friday, alleging that Moderna's COVID-19 vaccine Spikevax infringed CureVac ...
April 21 (Reuters) - Moderna (MRNA.O), opens new tab said on Tuesday the European Commission had approved its combination vaccine for the prevention of influenza and COVID-19 in adults 50 years of ...
Moderna is launching a large-scale clinical trial of a shot to combat bird flu in humans after Health and Human Services Secretary Robert F. Kennedy Jr.’s department had canceled hundreds of millions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results